EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS017-03729 
Organism
Homo sapiens 
Tissue/cell
CD14+_monocyte 
Coordinate
chr10:22903750-22905580 
TF binding sites/motifs
Number: 2             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
Gata1MA0035.3chr10:22905346-22905357ACAGATAAGGA-6.14
NFIL3MA0025.1chr10:22904401-22904412ATGTTACATAA-6.32
Number of super-enhancer constituents: 25             
IDCoordinateTissue/cell
SE_03224chr10:22900683-22904908Brain_Angular_Gyrus
SE_03224chr10:22904985-22907174Brain_Angular_Gyrus
SE_03934chr10:22898558-22908290Brain_Anterior_Caudate
SE_04774chr10:22891981-22927158Brain_Cingulate_Gyrus
SE_05852chr10:22898163-22913491Brain_Hippocampus_Middle
SE_06702chr10:22891742-22925122Brain_Hippocampus_Middle_150
SE_07788chr10:22892054-22927185Brain_Inferior_Temporal_Lobe
SE_09886chr10:22903801-22907187CD14
SE_10492chr10:22903840-22905939CD19_Primary
SE_10980chr10:22884677-22911330CD20
SE_11828chr10:22903692-22905874CD3
SE_14388chr10:22903853-22906056CD4_Memory_Primary_7pool
SE_16302chr10:22903655-22906078CD4_Naive_Primary_8pool
SE_17834chr10:22892759-22908318CD4p_CD25-_CD45ROp_Memory
SE_18302chr10:22897230-22908166CD4p_CD25-_Il17-_PMAstim_Th
SE_19467chr10:22904349-22905913CD4p_CD25-_Il17p_PMAstim_Th17
SE_19976chr10:22883491-22928570CD56
SE_20756chr10:22903718-22906013CD8_Memory_7pool
SE_22003chr10:22903623-22905768CD8_Naive_8pool
SE_22289chr10:22885022-22948957CD8_primiary
SE_32693chr10:22903816-22905972GM12878
SE_52957chr10:22904521-22905576Small_Intestine
SE_54406chr10:22903956-22904378Spleen
SE_54406chr10:22904547-22905617Spleen
SE_62312chr10:22885182-22974515Tonsil
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 3             
ChromosomeStartEnd
chr102290412822904400
chr102290456922905553
chr102290463922904845
Number: 1             
IDChromosomeStartEnd
GH10I022596chr102288516922927443
Enhancer Sequence
CTAAAATATA TTGCTTGTCT CTAGTTCAAA TTTTGGTGCA AATGCAGGTA ATGGCAATGA 60
GCTCCCAGAT TGAAGAAGGC TGAGTTAATC CTATTTGTTA ACTTCAATAT TTTATATAGC 120
GCTCTGGGCT GTGAACTTTC AGATTTCAAA ATAAAGATTC TTGGGTTTCA AAGTCTCCAG 180
TTTTAGAAAA CTTTAAATTA TTAGTTTGGC ATCCTACCTA GACCAACCAT TCTATATGAT 240
CTACCCTAAA ATTGATAACT AACAGTGGTT TATCATCATT ATTTTACACT TATTATCAGG 300
ATTTTTTTTT TAAAAGATAG GGTTGCTCAG GCTGGAGTGC AGGGGCATGA TCATGGCCAA 360
CTGCAGTCTT GAACTCCCAG GCTCAAGCAG TCCTCCTGCC TCAGTCTTCT GAGAGCTGGG 420
ACTACAGGCG CACACCACCA TGCATGGCTA ATTTTAAAAA TTTTTTTGTG GTGACAAGGT 480
CTTGCTATGT TGCCTGGGCT CAACAGATCC TCTTGCCTCA GCCTCTCAAA GTGTTGGAAT 540
CACAGGCATG AACCATCCCA CCTGTCCTTT CATCAGTATT TTTTATACAA AGAATTGACA 600
CTTTTCTAAG ATACTTATAT TGGGAACACG CACACATATA GTTCTATCTA TATGTTACAT 660
AATGTTCATA AAGGAAACAG AAAGATTTGT GTTAACCATT ACTGTTTTGA AGGAAAGAAT 720
CATACACCCT TTATAGGAAT AAGCATATAT TGTGAAATCC AAACAGTTTT TAATTCATGA 780
AGATGAAAGT GGTTTTTGAG TTTATTAAAA TTTTCTTAGG TTAGCTGAAC AAAGTGAAAG 840
CACCAGTTAT ACTATCACAT ACAGGCCACC TTTAAGGTTC CTTCAGGTTG CAAATATTCA 900
ATAAAATTCT CACAGCAAAA GAGCAATATC ACTTTACACT TAATGGTTGT CAAATACTTA 960
ATGGTTGTCA ATCCCCTTTG GCAAACACAG TATAGTTCTC TCTGTACTGC TGGTCACACT 1020
CACAGGCCTG TAAAACAAGT GTATTAGAAA TTCCCCGCCC CACACAGAGT GGCTGGAGCC 1080
TGGGGCCCCA GGGCATCCTG GGAGCGACTT CTTGTTCCTG TTTATGCCGG ACTTCTTGTT 1140
CCTGTTTATG CCGTGCCAGT CACCCCCAAA TTGCAGGTGT GGGTCTGCAC TGCCTTGCTG 1200
CCCGGCCATT GGGCATCAAA GCTGCCCATG CTGGGGCTCC AAAGATGACA TAAAATAAAG 1260
CAGCTTTGTT GTCTGCATCA ATAGAAACAG GGTCAAACGG GGCGGAGAGG GCTAGTGCAG 1320
AGCGCCAAAA TGTCCCTGAT TATGGTATGA CTCAAGAGTG GGGGCAGGGG AGAGAGCAGA 1380
GGGGGAGCTG ACATGTGGCA GGGAGAGGGA GGAAGCCGGG GAGAGCTCCT CAGGCTTGGC 1440
TCAGCTTTAC CCTAACTCAC TGCCACACTT GGCACTAACC TTACGGCTCA TGCTAGGTGC 1500
ACATGTGCCA AGACCCACGT GAGGCACTCC ACACACAGTA TCTTATCTGA TCTTTACAAC 1560
CCAAGGGGGT AGAGGTGCTA TTATCATGCC CATTACACAG ATAAGGAAAT TGAGGCTTAG 1620
TGAGATTAGA AAAGGCCCAA GCTATTAAAC AGTAGAGCTG TACCTGGAAC TCAGTCCAAT 1680
CTTAAATCTT CTGCCAACAT AACTCACATG AGTTACCTGG AATATAAAAT TCAGGGAGCT 1740
GGACTGGCTG AGCCCAAGAT ACTTTCAAAT TCCTAACAGC CAGTGAGATA AGATTCCTAG 1800
CAACTTCATA AGATATCTGC CTGAAATTTA 1830